TD Cowen Sticks to Their Buy Rating for Madrigal Pharmaceuticals (MDGL)
TD Cowen analyst Ritu Baral maintained a Buy rating on Madrigal Pharmaceuticals (MDGL – Research Report) today and set a price target of ...
Evercore ISI Sticks to Its Buy Rating for 89bio (ETNB)
Evercore ISI analyst Liisa Bayko maintained a Buy rating on 89bio (ETNB – Research Report) yesterday and set a price target of $33.00. The ...
Healio2h
Larsucosterol flops on clinical benefit in phase 2b alcohol-associated hepatitis trial
The AHFIRM trial did not demonstrate a beneficial effect of larsucosterol on 90-day mortality or the need for liver transplant among patients with severe alcohol-associated hepatitis, or AH, according ...